Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients
Abstract To evaluate the prognostic factors in adult cancer patients with pneumococcal bacteremia, describe episode features and the phenotypic characteristics of the isolated strains. We evaluated the episodes in patients admitted to a cancer hospital between 2009 and 2015. The outcomes were define...
Guardado en:
Autores principales: | Naihma Salum Fontana, K. I. Ibrahim, P. R. Bonazzi, F. Rossi, S. C. G. Almeida, F. M. Tengan, M. C. C. Brandileone, E. Abdala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7f273b780024cff9e34794e6eb012f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients
por: Naihma Salum Fontana, et al.
Publicado: (2021) -
Induction of prophages by fluoroquinolones in Streptococcus pneumoniae: implications for emergence of resistance in genetically-related clones.
por: Elena López, et al.
Publicado: (2014) -
No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia
por: Shi Thong Heng, et al.
Publicado: (2018) -
Association of methicillin resistance with mortality of hospital-acquired bacteremia
por: Tomonori Aratani, et al.
Publicado: (2021) -
Laboratory identification and clinical characteristics of Streptococcus bovis/Streptococcus equinus complex bacteremia: a retrospective, multicenter study in Hiroshima, Japan
por: Yuki Kaiki, et al.
Publicado: (2021)